Publication: Influence of CYP3A5 and SLCO1B1 polymorphisms on atazanavir/r concentrations in Thai HIV-infected patients
Issued Date
2019-05-24
Resource Type
ISSN
17448042
14622416
14622416
Other identifier(s)
2-s2.0-85066117677
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Pharmacogenomics. Vol.20, No.7 (2019), 517-527
Suggested Citation
Noppaket Singkham, Anchalee Avihingsanon, Narukjaporn Thammajaruk, Kiat Ruxrungtham, Torsak Bunupuradah, Sasisopin Kiertiburanakul, Ploenchan Chetchotisakd, David M. Burger, Sean Emery, Baralee Punyawudho Influence of CYP3A5 and SLCO1B1 polymorphisms on atazanavir/r concentrations in Thai HIV-infected patients. Pharmacogenomics. Vol.20, No.7 (2019), 517-527. doi:10.2217/pgs-2018-0196 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/50175
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Influence of CYP3A5 and SLCO1B1 polymorphisms on atazanavir/r concentrations in Thai HIV-infected patients
Other Contributor(s)
University of New South Wales (UNSW) Australia
Chulalongkorn University
Faculty of Medicine, Khon Kaen University
The HIV Netherlands Australia Thailand Research Collaboration
Faculty of Medicine, Ramathibodi Hospital, Mahidol University
Radboud University Nijmegen Medical Centre
Chiang Mai University
Chulalongkorn University
Faculty of Medicine, Khon Kaen University
The HIV Netherlands Australia Thailand Research Collaboration
Faculty of Medicine, Ramathibodi Hospital, Mahidol University
Radboud University Nijmegen Medical Centre
Chiang Mai University
Abstract
© 2019 Future Medicine Ltd. Aim: To evaluate the influence of genetic polymorphisms on plasma trough concentrations of atazanavir (ATV) and ritonavir (RTV). Patients & methods: The concentration-to-dose ratios were compared between different genotype groups of CYP3A5, ABCB1, SLCO1B1 and NR1I2 in 490 patients. Multiple regression analysis was used to examine the association between genetic and clinical factors and log-transformed concentration-to-dose ratio of ATV and RTV. Results: Higher concentrations of ATV and RTV were significantly associated with CYP3A5 6986 GG and SLCO1B1 521 TC or CC. Female patients had significantly higher ATV plasma concentration than male patients. Conclusion: Genetic polymorphisms and gender are factors affecting the variability of ATV and RTV concentrations in the Thai population. Thus, genetic testing is worth considering when atazanavir + low dose ritonavir is prescribed.
